Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

248
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
248
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

312
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
312
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

727
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
727
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

324
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
324
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.2K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.2K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

452
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
452

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can increased cognitive load help people with subthreshold depression to forget negative information?

Journal of affective disorders·2021
Same author

Vacuolin-1 inhibits endosomal trafficking and metastasis via CapZβ.

Oncogene·2021
Same author

CTPA pulmonary artery distensibility in assessment of severity of acute pulmonary embolism and right ventricular function.

Medicine·2021
Same author

The complete chloroplast genome of <i>Castanopsis mekongensis</i> A. Camus (Fagaceae).

Mitochondrial DNA. Part B, Resources·2021
Same author

3D images of the silicone implants in capsular contracture after breast augmentation using magnetic resonance imaging with SPACE sequence.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2021
Same author

High-efficient liquid exfoliation of 2D metal-organic framework using deep-eutectic solvents.

Ultrasonics sonochemistry·2021
Same journal

Mechanism of ribonucleic acid-binding protein ILF2 in promoting diabetic foot ulcer wound healing via regulating the nucleophosmin 1/NF-κB axis.

Burns & trauma·2026
Same journal

Organic light-emitting diode-based photodynamic therapy treats bacterial infection in a preclinical <i>ex vivo</i> burn wound model.

Burns & trauma·2026
Same journal

Diagnostic strategies in necrotizing soft tissue infections: from clinical scores to multi-omics and machine learning.

Burns & trauma·2026
Same journal

Advances in hemostatic biomaterials: biomimetic strategies, nanotechnology, and smart therapeutics.

Burns & trauma·2026
Same journal

Advances in microneedle design for the delivery of drugs, proteins, and cells in the treatment of hypertrophic scars.

Burns & trauma·2026
Same journal

Neutrophils and neutrophil extracellular traps in ischaemia-reperfusion injury: pathophysiological roles and therapeutic potential.

Burns & trauma·2026
See all related articles

Related Experiment Video

Updated: Mar 15, 2026

Two-photon Intravital Imaging of Leukocytes During the Immune Response in Lipopolysaccharide-treated Mouse Liver
07:06

Two-photon Intravital Imaging of Leukocytes During the Immune Response in Lipopolysaccharide-treated Mouse Liver

Published on: February 6, 2018

11.0K

Advances in sepsis-associated liver dysfunction.

Dawei Wang1, Yimei Yin2, Yongming Yao3

  • 1Department of Microbiology and Immunology, Burns Institute, First Hospital Affiliated to the Chinese PLA General Hospital, No.51 Fucheng Road, Haidian District, Beijing, 100048 China ; Department of ICU, Weihai Municipal Hospital, Weihai, Shandong, China.

Burns & Trauma
|September 8, 2016
PubMed
Summary
This summary is machine-generated.

Sepsis frequently causes early liver dysfunction due to inflammation and circulatory issues. Understanding sepsis-associated liver injury mechanisms is key to developing new treatments and improving patient survival rates.

Keywords:
Sepsisdysfunctioninflammationjaundiceliver

More Related Videos

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.9K
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.7K

Related Experiment Videos

Last Updated: Mar 15, 2026

Two-photon Intravital Imaging of Leukocytes During the Immune Response in Lipopolysaccharide-treated Mouse Liver
07:06

Two-photon Intravital Imaging of Leukocytes During the Immune Response in Lipopolysaccharide-treated Mouse Liver

Published on: February 6, 2018

11.0K
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.9K
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.7K

Area of Science:

  • Hepatology
  • Immunology
  • Critical Care Medicine

Background:

  • Liver dysfunction is an early sepsis complication.
  • Mechanisms include circulatory disturbances, bacterial endotoxins (lipopolysaccharide, LPS), and inflammatory cytokines.
  • Key liver cells involved are Kupffer cells (KCs), hepatocytes, and liver sinusoidal endothelial cells (LSECs).

Purpose of the Study:

  • To review the pathophysiology of sepsis-associated liver dysfunction.
  • To highlight the clinical manifestations and current treatment limitations.
  • To emphasize the need for better understanding to improve survival.

Main Methods:

  • Literature review of recent studies on sepsis and liver injury.
  • Analysis of cellular and molecular mechanisms involved in hepatic response to sepsis.
  • Categorization of clinical presentations and therapeutic strategies.

Main Results:

  • Sepsis-associated liver dysfunction arises from multiple factors including inflammation and microcirculatory impairment.
  • Clinical signs include hypoxic hepatitis and jaundice, with jaundice being more common.
  • Activated neutrophils exacerbate liver injury through enzymes and free radicals.

Conclusions:

  • No specific therapies currently exist for sepsis-associated liver dysfunction.
  • Management focuses on treating the infection and severe sepsis.
  • Further research into the pathophysiology is crucial for developing targeted treatments and improving outcomes.